Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?

Tyrosine Kinase Inhibitors in the Treatment of Metastasised Renal Cell Carcinoma—Future or the Past?

Background: To review and discuss the literature on applying tyrosine kinase inhibitors (TKIs) in the treatment of metastasised renal cell carcinoma (mRCC). Materials and Methods: Medline, PubMed, the Cochrane database, and Embase were screened for randomised controlled trials, clinical trials, and...

Full description

Bibliographic Details
Main Authors: Jakob Michaelis, Markus Grabbert, August Sigle, Mehmet Yilmaz, Daniel Schlager, Christian Gratzke, Arkadiusz Miernik, Dominik Stefan Schoeb
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
tyrosine kinase inhibitors
adjuvant therapy
immune checkpoint inhibitors
renal cell carcinoma
targeted therapy
Online Access:https://www.mdpi.com/2072-6694/14/15/3777

Internet

https://www.mdpi.com/2072-6694/14/15/3777

Similar Items